Related Experiment Video
Updated: Jul 13, 2026

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
Caffeine and accumbens shell dopamine
M A De Luca1, V Bassareo, A Bauer
1Department of Toxicology, University of Cagliari, Cagliari, Italy.
Caffeine and A1 antagonists do not increase dopamine in the nucleus accumbens shell. Increases are observed in the medial prefrontal cortex, suggesting probe placement influences results.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Conflicting reports exist regarding caffeine's effect on extracellular dopamine (DA) in the nucleus accumbens (NAc) shell.
- Previous studies suggest caffeine and A1 receptor antagonists may increase NAc shell DA, while others report no effect.
Purpose of the Study:
- To clarify the effects of caffeine and A1 receptor antagonists on extracellular DA levels in the NAc shell.
- To investigate the influence of microdialysis probe placement on observed DA changes.
Main Methods:
- Rats were administered caffeine (10 and 30 mg/kg i.p.) and A1 antagonists (DPCPX, CPFPX).
- Microdialysis probes were implanted in the NAc shell, medial prefrontal cortex (PFCX), or at the border between these regions.
- Dialysate DA levels were measured under different anesthetic conditions (chloral hydrate, ketamine).
Main Results:
- Caffeine and A1 antagonists did not alter DA levels when probes were exclusively in the NAc shell.
- A significant increase in DA was observed when probes were placed at the border of the NAc shell and PFCX, or within the PFCX.
- These findings were consistent regardless of the anesthetic used.
Conclusions:
- Caffeine does not directly increase extracellular DA in the NAc shell.
- Reported increases in NAc shell DA by caffeine likely originate from the medial PFCX due to probe misplacement.
- Accurate probe placement is critical for interpreting the effects of neuroactive substances in specific brain regions.
More Related Videos
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Abuse and Addiction: Pharmacological Phenomena
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

